Lyra Therapeutics (LYRA) Revenue (2021 - 2025)
Lyra Therapeutics (LYRA) recorded quarterly Revenue of $7000.0 in Q4 2025, down 72.0% on a QoQ basis from $25000.0 in Q3 2025, and down 96.65% YoY from $209000.0 in Q4 2024.
Lyra Therapeutics (LYRA) Revenue (2021 - 2025) Analysis & Trends
Lyra Therapeutics (LYRA) has reported Revenue for 5 consecutive years, with $7000.0 the latest figure, recorded in Q4 2025.
- Revenue for Q4 2025 came in at $7000.0, down 96.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $398000.0 (down 74.05% YoY), and the FY2025 annual result was $398000.0, down 74.05% from the prior year.
- Revenue for Q4 2025 stood at $7000.0, down from $25000.0 in the prior quarter.
- The five-year high for Revenue was $598000.0 in Q2 2024, with the low at $7000.0 in Q4 2025.
- A 5-year average of $285444.4 and a median of $240000.0 in 2021 frame the typical range for Revenue.
- Across the five-year window, Revenue surged 2464.29% in 2022 and sank 96.65% in 2025, its largest moves.
- Lyra Therapeutics' Revenue stood at $271000.0 in 2021, then slumped by 95.94% to $11000.0 in 2022, then jumped by 1227.27% to $146000.0 in 2023, then jumped by 43.15% to $209000.0 in 2024, then slumped by 96.65% to $7000.0 in 2025.
- The last three Revenue figures came in at $7000.0 (Q4 2025), $25000.0 (Q3 2025), and $183000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Mar 31, 2024 | 532,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | 544,000.00 |
| Jun 30, 2023 | 458,000.00 |
| Mar 31, 2023 | 410,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 359,000.00 |
| Jun 30, 2022 | 525,000.00 |
| Mar 31, 2022 | 468,000.00 |
| Dec 31, 2021 | 271,000.00 |
| Sep 30, 2021 | 14,000.00 |